We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
About this guideline
TGA adopted date: 26 Mar 2002
Categories: Clinical efficacy and safety | General (clinical)
TGA annotations
The TGA has published guidance on eligibility criteria and supporting documentation for orphan drug designation in accordance with Part 3B of the Therapeutic Goods Regulations 1990.
For more information see International scientific guidelines adopted in Australia.
Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.